These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9200406)

  • 1. Histological localization of advanced glycosylation end products in the progression of diabetic nephropathy.
    Imai N; Nishi S; Suzuki Y; Karasawa R; Ueno M; Shimada H; Kawashima S; Nakamaru T; Miyakawa Y; Araki N; Horiuchi S; Gejyo F; Arakawa M
    Nephron; 1997; 76(2):153-60. PubMed ID: 9200406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy.
    Nishino T; Horii Y; Shiiki H; Yamamoto H; Makita Z; Bucala R; Dohi K
    Hum Pathol; 1995 Mar; 26(3):308-13. PubMed ID: 7890283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of diabetic nephropathy in non-insulin-dependent diabetes mellitus.
    Kida H; Yoshimura M; Ikeda K; Saitou Y; Noto Y
    J Diabet Complications; 1991; 5(2-3):82-3. PubMed ID: 1770060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria.
    Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
    Nephrology (Carlton); 2012 Jan; 17(1):68-75. PubMed ID: 21933307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice.
    Schwedler SB; Verbeke P; Bakala H; Weiss MF; Vilar J; Depreux P; Fourmaintraux E; Striker LJ; Striker GE
    Diabetes Obes Metab; 2001 Aug; 3(4):230-9. PubMed ID: 11520302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions.
    Suzuki D; Miyata T; Saotome N; Horie K; Inagi R; Yasuda Y; Uchida K; Izuhara Y; Yagame M; Sakai H; Kurokawa K
    J Am Soc Nephrol; 1999 Apr; 10(4):822-32. PubMed ID: 10203367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy.
    Makino H; Shikata K; Hironaka K; Kushiro M; Yamasaki Y; Sugimoto H; Ota Z; Araki N; Horiuchi S
    Kidney Int; 1995 Aug; 48(2):517-26. PubMed ID: 7564121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
    Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
    J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological study of diabetic nephropathy in the elderly].
    Kanauchi M; Shiiki H; Fujii Y; Dohi K
    Nihon Ronen Igakkai Zasshi; 1996 Oct; 33(10):774-8. PubMed ID: 8958741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and morphometrical interrelationships in patients with overt nephropathy induced by non-insulin-dependent diabetes mellitus. A light- and electron-microscopy study.
    Matsumae T; Jimi S; Uesugi N; Takebayashi S; Naito S
    Nephron; 1999 Jan; 81(1):41-8. PubMed ID: 9884418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of advanced glycation endproducts in the kidney of experimental diabetic rats.
    Shikata K; Makino H; Sugimoto H; Kushiro M; Ota K; Akiyama K; Araki N; Horiuchi S; Ota Z
    J Diabetes Complications; 1995; 9(4):269-71. PubMed ID: 8573744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
    van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ
    Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
    Dalla Vestra M; Saller A; Mauer M; Fioretto P
    J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.
    Niwa T; Katsuzaki T; Miyazaki S; Miyazaki T; Ishizaki Y; Hayase F; Tatemichi N; Takei Y
    J Clin Invest; 1997 Mar; 99(6):1272-80. PubMed ID: 9077536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes.
    Beisswenger PJ; Makita Z; Curphey TJ; Moore LL; Jean S; Brinck-Johnsen T; Bucala R; Vlassara H
    Diabetes; 1995 Jul; 44(7):824-9. PubMed ID: 7789650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy.
    Koschinsky T; He CJ; Mitsuhashi T; Bucala R; Liu C; Buenting C; Heitmann K; Vlassara H
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6474-9. PubMed ID: 9177242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of kidney and muscle biopsy specimens from identical twins discordant for type I diabetes mellitus.
    Steffes MW; Sutherland DE; Goetz FC; Rich SS; Mauer SM
    N Engl J Med; 1985 May; 312(20):1282-7. PubMed ID: 4039409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial derangement: possible initiator of microalbuminuria in NIDDM.
    Takebayashi S; Kaneda K
    J Diabet Complications; 1991; 5(2-3):104-6. PubMed ID: 1770011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.